FIELD: medicine, pediatrics.
SUBSTANCE: the present innovation deals with antenatal prophylaxis of transitive myocardial dysfunction in neonatals before their birth. One should introduce limontar daily per 1 tablet for pregnant women at the period of 35-36 wk gestation additionally to conventional therapy. It is necessary to conduct one course of prophylaxis for 14 d. The innovation provides normalization of myocardial contractile function in neonatals and prophylaxis in development of side effects caused by the preparation introduced.
EFFECT: higher efficiency of prophylaxis.
3 ex, 1 tbl
Authors
Dates
2005-10-20—Published
2003-06-05—Filed